Arfid, 2017
Arfid, 2017
Arfid, 2017
Avoidant/restrictive food intake disorder (ARFID) is an and medical and psychiatric comorbidities of this patient
entirely new diagnosis in the DSM-5. ARFID replaces “feed- population are described and compared to other eating
ing disorder of infancy or early childhood,” which was a disorders. Evaluation and management strategies are also
diagnosis in the DSM-IV restricted to children 6 years of age discussed. No data yet exist regarding ARFID’s prognosis
or younger; ARFID has no such age limitations and it is and prevention; however, recommendations to guide parents
distinct from anorexia nervosa and bulimia nervosa in that in establishing appropriate infant and child feeding practices
there is no body image disturbance. ARFID involves a are provided.
complex and heterogenous etiology, which is reviewed
herein. What is known to date regarding the characteristics Curr Probl Pediatr Adolesc Health Care 2017;47:95-103
Two non-eating disorder focused studies have be diagnosed with PANS/PANDAS, there must be acute
reported on prevalence rates of ARFID in the general onset of either obsessive-compulsive disorder (OCD) or
pediatric population. In the first study, researchers severely restricted eating, as well as multiple neuro-
examined 2231 consecutive new referrals to pediatric psychiatric symptoms. Restrictions in food intake are
gastroenterology specialty clinics via retrospective typically due to fears of food contamination, choking,
chart review.5 Patients were 8–18 years old and 1.5% swallowing, or sensory concerns, all of which could also
(33 patients) were found to have a diagnosis of be present in a patient with ARFID. All PANS cases
ARFID. One or more ARFID symptoms were present described involved food restriction and also met criteria
in an additional 54 patients (2.4%), but a diagnosis for ARFID. The authors highlight important differences
could neither be assigned nor excluded based on in presentation of PANS/PANDAS (primarily the
available chart information. There were very few cases acuity of symptom onset) as well as in treatment and
of other eating disorders (three cases of AN, two cases outcomes. According to the authors, antibiotic or
of BN, and one case of BED). immunomodulatory therapy often results in swift symp-
In the second study, researchers reviewed 29 cases of tom resolution of PANS/PANDAS. This study points
pediatric acute-onset neuropsychiatric syndrome out the need for consideration of a PANS/PANDAS
(PANS) and pediatric acute-onset neuropsychiatric diagnosis in patients with acute onset of restrictive
disorder associated with streptococcal infections eating or food avoidance, without prior history of picky
(PANDAS) in children ages 5-12 years.13 In order to eating.